. 2023 Nov 20;15:157. doi: 10.1186/s13102-023-00769-2

Table 3.

Comparison of within and between group SF36 scores

	US n = 31	KDD n = 31	Control n = 20	Between group p values
Physical functioning
Before treatment	45.74 ± 21.26^b	47.09 ± 20.72^b	59.00 ± 27.65^b	0.104^*
1st month after treatment	61.51 ± 24.06^b	66.77 ± 20.02^b	73.00 ± 17.72^b	0.172^*
3rd month after treatment	61.61 ± 26.43^b	70.48 ± 19.20^b	75.00 ± 17.91^b	0.087^*
Within group p	0.003^**	< 0.001^**	0.036^**
Role -physical
Before treatment	0 (0–100)^c,d	0 (0–100)^c,d	87.5 (0–100)^c	0.002^***
1st month after treatment	75 (0–100)^d	100 (0–100)^d	100 (0–100)	0.114^***
3rd month after treatment	75 (0–100)^d	100 (0–100)^d	100 (0–100)	0.063^***
Within group p	< 0.001^****	< 0.001^****	0.063^****
Role -emotional
Before treatment	34.38 ± 39.93^a,b	47.29 ± 47.75^b	68.30 ± 39.75^a	0.027^*
1st month after treatment	64.54 ± 41.24^b	76.32 ± 39.65^b	80.00 ± 41.03	0.347^*
3rd month after treatment	63.35 ± 41.70^b	81.67 ± 35.37^b	85.00 ± 36.63	0.081^*
Within group p	0.001^**	0.006^**	0.110^**
Vitality
Before treatment	45.48 ± 14.16^b	48.38 ± 18.63^b	49.50 ± 17.31	0.576^*
1st month after treatment	54.83 ± 15.62^b	56.45 ± 21.45^b	49.75 ± 16.50	0.234^*
3rd month after treatment	55.80 ± 19.58^b	56.29 ± 23.55^b	49.00 ± 18.32	0.075^*
Within group p	0.005^*	0.019^*	0.957^*
Emotional well-being
Before treatment	56.25 ± 15.69^b	58.70 ± 16.21^b	61.10 ± 12.40	0.382^*
1st month after treatment	63.48 ± 13.13^b	65.03 ± 16.68	61.30 ± 15.30	0.367^*
3rd month after treatment	62.00 ± 19.34	67.61 ± 17.83^b	61.15 ± 15.13	0.671^*
Within group p	0.029^*	0.021^*	0.996^*
Social functioning
Before treatment	50 (25–88)^d	50 (25–100)^d	63 (10–100)^d	0.272^***
1st month after treatment	63 (37.5–100)^d	87.5 (0–100)^d	87.5 (13–100)^d	0.221^***
3rd month after treatment	63 (13–100)^c,d	100 (37.5–100)^c,d	88 (50–100)^d	0.012^***
Within group p	0.001^****	< 0.001^****	< 0.001^****
Pain
Before treatment	38 (0–68)^c,d	45 (0–80)^d	45 (23–70)^c,d	0.007^***
1st month after treatment	48 (10–100)^d	67.5 (35–100)^d	67.5 (20–90)^d	0.233^***
3rd month after treatment	58 (10–100)^d	70 (22.5–100)^d	63.7 (22.5–90)^d	0.753^***
Within group p	< 0.001^****	< 0.001^****	0.021^****
General health
Before treatment	50 (25–80)	60 (20–85)^d	57.5 (25–100)	0.132^***
1st month after treatment	55 (30–80)	65 (15–95)	57.5 (30–100)	0.330^***
3rd month after treatment	55 (25–95)	65 (30–95)^d	62.5 (30–100)	0.215^***
Within group p	0.248****	0.030^****	0.590****
Mental Health
Before treatment	38.70 ± 18.07^b	34.51 ± 15.24^b	42.25 ± 18.60	0.285^*
1st month after treatment	60.48 ± 26.43^b	59.67 ± 23.87^b	52.50 ± 26.77	0.514^*
3rd month after treatment	56.61 ± 30.77^b	56.41 ± 25.77^b	57.50 ± 27.02	0.990^*
Within group p	< 0.001^**	< 0.001^**	0.099^**

^*One way ANOVA Test (^aPosthoc: Bonferroni)

^**Repeated Measures ANOVA Test (^bPost hoc: Paired samples T test)

^***Kruskal Wallis Test (^cBonferroni corrected Mann Whitney U Test, p < 0.016)

^****Friedman Test (^dPosthoc: Wilcoxon Signed Ranks Test)